Exparel Use in Adductor Canal Block After Total Knee Arthroplasty

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Exparel has been shown to have better pain control compared to previously used infiltration agents, including bupivacaine, while having a minor side effect profile. The purpose of this study is to explore the effectiveness of Exparel (liposomal bupivacaine) in Adductor Canal Blocks for peri-operative pain control following a total knee arthroplasty (TKA) procedure.
Epistemonikos ID: 16261e5088baf1766f121274debf243d9267928f
First added on: May 08, 2024